TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
TLX GlobeNewsWire — November 11, 2025NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ: TLX) and certain of its officers.
Waters Corporation to Present at the Jefferies Global Healthcare Conference in London — Neutral
WAT PRNewsWire — November 11, 2025MILFORD, Mass. , Nov. 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Realty Income offers a 5.7% dividend yield and targets 10% annual returns over five years, with a $70 price target. O boasts a diversified $85 billion portfolio, resilient performance through downturns, and a 30-year record of rising dividends. Long-term growth is supported by disciplined acquisitions, though reliance on equity dilution and expansion into new markets pose risks.
Johnson Fistel Investigates Fairness of Proposed Sale of Metsera — Neutral
PFE GlobeNewsWire — November 11, 2025SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, has launched an investigation into whether the board members of Metsera, Inc. (NASDAQ: MTSR) breached their fiduciary duties in connection with the proposed sale of the Company to Pfizer, Inc. (NYSE: PFE).
Kratos Defense Rises 280.4% YTD: Should You Hold or Fold the Stock? — Positive
KTOS Zacks Investment Research — November 11, 2025KTOS' 200% stock surge in 2025 reflects booming unmanned systems demand and strategic deals fueling its growth momentum.
DELL vs. SMCI: Which AI-Server Stock Should You Buy Right Now? — Positive
DELL SMCI Zacks Investment Research — November 11, 2025Dell Technologies' surging AI server sales and expanding PowerEdge lineup position it ahead of Super Micro Computer, which faces platform delays and stretched valuation.
Vistra Q3 Earnings Beat Estimates, Revenues Lag, '25 Guidance Narrowed — Positive
VST Zacks Investment Research — November 11, 2025Vistra tops Q3 earnings forecasts but misses on revenues, trims 2025 outlook, and continues its aggressive share buybacks.
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus — Negative
IMVT Zacks Investment Research — November 11, 2025Immunovant posts a wider Q2 loss as R&D spending rises, but progress on IMVT-1402 and batoclimab fuels its pipeline momentum.
First Horizon Stock Rises Nearly 9% in 6 Months: Is It Worth Buying Now? — Positive
FHN Zacks Investment Research — November 11, 2025Can FHN's steady loan growth, steady NII gains, and shareholder-friendly moves outweigh its expense pressures? Let's find out.
Cognizant Shares Ride on AI Deployment, Expanding Partner Base — Positive
CTSH Zacks Investment Research — November 11, 2025CTSH shares surge as its AI-led productivity gains, major partnerships, and upbeat 2025 guidance fuel investor confidence.
Here's Why Lumentum Stock Is a Promising Portfolio Pick Right Now — Positive
LITE Zacks Investment Research — November 11, 2025LITE's surging AI-driven demand for laser chips and optical transceivers fuels a 209.5% YTD stock rally and strong growth outlook.
Tidewater Inc. (TDW) Q3 2025 Earnings Call Transcript — Neutral
TDW Seeking Alpha — November 11, 2025Tidewater Inc. ( TDW ) Q3 2025 Earnings Call November 11, 2025 9:00 AM EST Company Participants West Gotcher - Senior Vice President of Strategy, Corporate Development & IR Quintin Kneen - President, CEO & Director Piers Middleton - Executive VP & Chief Operating Officer Samuel Rubio - Executive VP & CFO Conference Call Participants James Rollyson - Raymond James & Associates, Inc., Research Division Fredrik Stene - Clarksons Platou Securities AS, Research Division Joshua Jayne - Daniel Energy Partners, LLC Gregory Lewis - BTIG, LLC, Research Division Presentation Operator Thank you for standing by. My name is Liz, and …
Tariffs Test Margins, Campaigns Fuel Traffic: Can AEO Balance Both? — Negative
AEO Zacks Investment Research — November 11, 2025AEO battles tariff-driven margin hits with cost cuts and viral campaigns, using denim demand and star power to sustain growth.
AVO Beyond Avocados: Can Mangoes & Blueberries Drive Future Growth? — Neutral
AVO Zacks Investment Research — November 11, 2025Mission Produce is branching beyond avocados, betting on mangoes and blueberries as its next growth engines.
DoorDash Rises 22% Year to Date: Buy, Sell, or Hold the Stock? — Positive
DASH Zacks Investment Research — November 11, 2025DASH's expanding partnerships and strong order growth drive optimism, but fierce competition and high valuation keep investors cautious.
SMX's Global Web of Partnerships Turns Gold Transparent, Fashion Traceable, and Technology Accountable — Neutral
SMX Accesswire — November 11, 2025NEW YORK, NY / ACCESS Newswire / November 11, 2025 / There comes a point in every company's journey when innovation stops being an idea and becomes infrastructure. SMX (NASDAQ:SMX) has reached that point.
CLASS ACTION REMINDER: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Lawsuit by December 15, 2025 — Neutral
MLTX PRNewsWire — November 11, 2025PHILADELPHIA , Nov. 11, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September 29, 2025 (the "Class Period"). Investor Deadline: Investors who purchased MoonLake securities during the Class Period may, no later than December 15, 2025 , seek to be appointed as a lead plaintiff representative of the class.
Baxter International Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the BAX Securities Class Action — Neutral
BAX GlobeNewsWire — November 11, 2025SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Company: Baxter International, Inc. (NYSE: BAX) is a global company that develops, manufactures, and markets medical products used in hospitals and other healthcare facilities. Class Period: February 23, 2022 and July 30, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of certain investors who purchased or otherwise acquired Baxter International, Inc. because the Company allegedly mislead investors regarding the safety of its Novum LVP device.
CoreWeave displays impressive AI-driven growth but faces concerns over heavy capital spending, rising debt, and modest operating profits. Sequential revenue growth is slowing, with Q3 revenues at $1.36 billion and operating profits offset by ballooning interest expenses. The company maintains a large backlog and continues to invest aggressively, but net debt has surged to $11 billion, and profitability remains elusive.